Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-07

Clinical Trial Update: Effect of PERMEAPROTECT on the Quality of Life of Patients With Fibromyalgia [NA]

View source ↗

Summary

This update covers a clinical trial evaluating PERMEAPROTECT for improving quality of life in fibromyalgia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERMEAPROTECT

Snippet

Sponsor: Lescuyer Laboratory | Conditions: Fibromyalgia | NA | Status: UNKNOWN